87 related articles for article (PubMed ID: 15700798)
1. [Meta-analysis of randomized clinical studies. Hawthorn extract for treatment of chronic cardiac insufficiency].
Pittler MH; Schmidt K; Ernst E
Pharm Unserer Zeit; 2005; 34(1):66-71. PubMed ID: 15700798
[No Abstract] [Full Text] [Related]
2. Hawthorn extract improves chronic heart failure.
Eaton LJ; Kinkade S
J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
[No Abstract] [Full Text] [Related]
3. Hawthorn--Crataegus monogyna (common hawthorn) or Crataegus laevigata (midland hawthorn; Crataegus oxyacantha); also known as haw, thornapple, maythorn, whitethorn.
Rasmussen P
J Prim Health Care; 2011 Mar; 3(1):63-4. PubMed ID: 21359265
[No Abstract] [Full Text] [Related]
4. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
Pittler MH; Schmidt K; Ernst E
Am J Med; 2003 Jun; 114(8):665-74. PubMed ID: 12798455
[TBL] [Abstract][Full Text] [Related]
5. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
Habs M
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hawthorn extract on immunomodulatory biomarkers in a pressure overload model of heart failure.
Bleske BE; Zineh I; Hwang HS; Welder GJ; Ghannam MM; Boluyt MO
Med Sci Monit; 2007 Dec; 13(12):BR255-8. PubMed ID: 18049426
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
9. [Methods of evaluating the treatment of cardiac insufficiency].
Zannad F; Lechat P
Arch Mal Coeur Vaiss; 1990 Jan; 83(1):91-8. PubMed ID: 2137688
[No Abstract] [Full Text] [Related]
10. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract.
Tadić VM; Dobrić S; Marković GM; Dordević SM; Arsić IA; Menković NR; Stević T
J Agric Food Chem; 2008 Sep; 56(17):7700-9. PubMed ID: 18698794
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
13. [Mild heart failure. With hawthorn fit again in routine exertion].
MMW Fortschr Med; 2012 Jun; 154(11):78-9. PubMed ID: 22838139
[No Abstract] [Full Text] [Related]
14. The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure.
Zick SM; Blume A; Aaronson KD
J Card Fail; 2005 Oct; 11(8):586-9. PubMed ID: 16230260
[TBL] [Abstract][Full Text] [Related]
15. [Crataegus oxyacantha (aubepine) in the use as herb medicine in France].
Ju LY
Zhongguo Zhong Yao Za Zhi; 2005 Apr; 30(8):634-40. PubMed ID: 16011292
[TBL] [Abstract][Full Text] [Related]
16. Should we use anticoagulation for patients with chronic heart failure?
Freudenberger RS; Halperin JL
Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):580-1. PubMed ID: 17063158
[No Abstract] [Full Text] [Related]
17. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
Van Tassell BW; Radwanski P; Movsesian M; Munger MA
Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
[TBL] [Abstract][Full Text] [Related]
19. Using Cardicor as first-line therapy in heart failure : CiBis iii.
Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
[No Abstract] [Full Text] [Related]
20. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
Fortuna P; Reis I; Ascenção R; Carneiro AV
Rev Port Cardiol; 2008; 27(7-8):977-89. PubMed ID: 18959094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
